*Note: For consistency, wattage ranges and starting prices listed above apply only to standby generators. Other generator types, such as portable and inverter generators, may have different power ...
AI video generators help you turn your prompts into believable videos, complete with audio. We've tested all the top services to help you choose the one that does the best job with the fewest tweaks.
A configurable Python/Tkinter GUI tool for turning Discord member-list CSV exports into whitelist .txt files. It is designed for VRChat world whitelists, Patreon tier lists, age verification lists, ...
STERLING, Va. — Not long after the enormous data center sprouted in Jessica Medeiros’s residential neighborhood, she began seeing black smoke. “There are times when the generators are running and … ...
AI has taken the world by storm over the last few years, with millions of users writing prompts on platforms like ChatGPT to generate content, images, and yes videos. Still, some of these platforms ...
With U.S. electricity demand starting to rise quickly and expected to continue rising, largely because of the power needed for data centers that process artificial intelligence, people are looking for ...
Nearly 150,000 generators sold at stores like Home Depot and Lowe’s are being recalled for posing a deadly fire hazard. According to an April 16 warning from the U.S. Consumer Product Safety ...
Feb 27 (Reuters) - Flagship-backed Generate Biomedicines' shares fell more than 6% in their Nasdaq debut on Friday, giving the drug developer a valuation of $1.91 billion, as lingering market ...
Despite wide availability of biologic drugs for asthma, use of these injectable medicines remains low — patients just dislike frequent injections. Generate Biomedicine’s lead drug candidate could ...
Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...
Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...
Generate Biomedicines Inc. raised $400 million in an initial public offering, pricing its shares at the midpoint of the marketed range. The Somerville, Massachusetts-based drug developer sold 25 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results